100 related articles for article (PubMed ID: 2477679)
1. [Immunohistochemical study of cytokeratin in esophageal carcinoma: preliminary report].
Mio H; Kumasiro R; Ikenaga H; Maekawa T; Inutsuka S; Murayama H; Kikuchi M
Nihon Geka Gakkai Zasshi; 1989 May; 90(5):793. PubMed ID: 2477679
[No Abstract] [Full Text] [Related]
2. Immunohistochemical staining with cytokeratin combining semi-serial sections for detection of cervical lymph node metastases of oral squamous cell carcinoma.
Guo CB; Li YA; Gao Y
Auris Nasus Larynx; 2007 Sep; 34(3):347-51. PubMed ID: 17399927
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistological evaluation of esophageal cancer with antikeratin monoclonal antibodies].
Tanimura S
Nihon Geka Gakkai Zasshi; 1995 Nov; 96(11):741-52. PubMed ID: 8569674
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic evaluation of squamous cell carcinoma of the esophagus].
Kolosov AE; Dovgaliuk AZ; Stoliarov VI
Sov Med; 1991; (10):68-9. PubMed ID: 1801242
[No Abstract] [Full Text] [Related]
5. Does the TNM staging system for esophageal cancer need revision?
Pramesh CS; Mistry RC; Jambhekar NA; Laskar SG
J Am Coll Surg; 2006 May; 202(5):855-6; author reply 856. PubMed ID: 16648030
[No Abstract] [Full Text] [Related]
6. Clinicopathological and immunohistochemical characteristics of esophageal carcinosarcoma.
Sano A; Sakurai S; Kato H; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Sakamoto K; Sano T; Hosoya Y; Enomoto T; Kanda T; Ajioka Y; Oyama T; Kuwano H
Anticancer Res; 2009 Aug; 29(8):3375-80. PubMed ID: 19661359
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of CD151 expression in esophageal squamous cell carcinoma with aggressive cell proliferation and invasiveness.
Suzuki S; Miyazaki T; Tanaka N; Sakai M; Sano A; Inose T; Sohda M; Nakajima M; Kato H; Kuwano H
Ann Surg Oncol; 2011 Mar; 18(3):888-93. PubMed ID: 20978946
[TBL] [Abstract][Full Text] [Related]
8. [Understanding and appraisal of the new TNM classification for esophageal cancer in the AJCC Cancer Staging Manual (7th edition)].
Chen LQ
Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):237-40. PubMed ID: 20450597
[No Abstract] [Full Text] [Related]
9. FOXC2 is a novel prognostic factor in human esophageal squamous cell carcinoma.
Nishida N; Mimori K; Yokobori T; Sudo T; Tanaka F; Shibata K; Ishii H; Doki Y; Mori M
Ann Surg Oncol; 2011 Feb; 18(2):535-42. PubMed ID: 20803080
[TBL] [Abstract][Full Text] [Related]
10. [Impact of the pattern of lymph node metastasis on the clinical target volume in radiotherapy for thoracic esophageal squamous cell carcinoma].
Huang W; Li BS; Gong HY; Fan M; Sun HF; Zhou T; Liu XB
Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):225-8. PubMed ID: 20450594
[TBL] [Abstract][Full Text] [Related]
11. [Correlation between expression of E-cadherin and metastases in human esophageal cancer: preliminary report].
Miyata M; Shiozaki H; Kobayashi K; Yano H; Tamura S; Tahara H; Mori T
Nihon Geka Gakkai Zasshi; 1990 Nov; 91(11):1761. PubMed ID: 2277627
[No Abstract] [Full Text] [Related]
12. Keratin expression in normal esophageal epithelium and squamous cell carcinoma of the esophagus.
Grace MP; Kim KH; True LD; Fuchs E
Cancer Res; 1985 Feb; 45(2):841-6. PubMed ID: 2578311
[TBL] [Abstract][Full Text] [Related]
13. Low expression of claudin-4 is associated with poor prognosis in esophageal squamous cell carcinoma.
Sung CO; Han SY; Kim SH
Ann Surg Oncol; 2011 Jan; 18(1):273-81. PubMed ID: 20839069
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic and immunohistochemical features of surgically resected small cell carcinoma of the esophagus.
Osugi H; Takemura M; Morimura K; Kaneko M; Higashino M; Takada N; Lee S; Kinoshita H
Oncol Rep; 2002; 9(6):1245-9. PubMed ID: 12375028
[TBL] [Abstract][Full Text] [Related]
15. STC2: a predictive marker for lymph node metastasis in esophageal squamous-cell carcinoma.
Kita Y; Mimori K; Iwatsuki M; Yokobori T; Ieta K; Tanaka F; Ishii H; Okumura H; Natsugoe S; Mori M
Ann Surg Oncol; 2011 Jan; 18(1):261-72. PubMed ID: 20734150
[TBL] [Abstract][Full Text] [Related]
16. The expression pattern of vascular endothelial growth factor C and D in human esophageal normal mucosa, dysplasia and neoplasia.
Ishikawa M; Kitayama J; Kazama S; Nagawa H
Hepatogastroenterology; 2004; 51(59):1319-22. PubMed ID: 15362742
[TBL] [Abstract][Full Text] [Related]
17. Strong impact of micrometastatic tumor cell load in patients with esophageal carcinoma.
Koenig AM; Prenzel KL; Bogoevski D; Yekebas EF; Bubenheim M; Faithova L; Vashist YK; Gawad KA; Baldus SE; Pantel K; Schneider PM; Hölscher AH; Izbicki JR
Ann Surg Oncol; 2009 Feb; 16(2):454-62. PubMed ID: 19015923
[TBL] [Abstract][Full Text] [Related]
18. [Expression and biological significance of HPA and HIF-1alpha in human esophageal squamous cell carcinoma].
Liu JL; Zhou BJ; Zhang Y; Wu YP; Liu SZ; G A O WM; Xue J; Liu WH
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):689-92. PubMed ID: 18246800
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma.
Glickman JN; Torres C; Wang HH; Turner JR; Shahsafaei A; Richards WG; Sugarbaker DJ; Odze RD
Cancer; 1999 Feb; 85(4):769-78. PubMed ID: 10091753
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinomas, an immunohistochemical and ultrastructural study.
Suo Z; Holm R; Nesland JM
Anticancer Res; 1992; 12(6B):2025-31. PubMed ID: 1284199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
